Press Releases


27.10.2004

BioRegio Regensburg Makes Contacts in Asia

Thanks to innovative products, some BioPark companies have begun making profits. After the USA, Asia has now become a likely market. BioPark Regensburg and companies from the region took advantage of the closely scheduled trade shows in Japan and Singapore and made their first successful business contacts.

read on

20.10.2004

BioPark Becomes Part of Strategic Partnership in Brazil

The region Belo Horizonte, in the Brazilian State of Minas Gerais, has become one of the largest biotechnology-clusters in the country. The management of the local BioRegio organization “Fundação Biominas” has signed an agreement with the Bavarian region, i.e. BioPark GmbH.

read on

27.08.2004

Center for Medical Biotechnology Opens at BioPark

The final cornerstone at BioPark, the Center for Medical Biotechnology has opened. At the new center, researchers can combine their know-how in the field of tissue engineering with regeneration medicine. Seven workgroups, from various research disciplines at the university, clinic and from the region, share a 500 sqm facility.

read on

20.08.2004

Geneart One of the 10 Most Fascinating Innovations

The Regensburg based biotech company, Geneart GmbH, was honored as one of the winners, in the field of humanity and high-tech, in the „Potential Innovation“ competition sponsored by the German Industrial and Trade Commission (DIHK) and the Financial Times Deutschland (FTD).

read on

27.07.2004

EuroVacc successfully completes first clinical phase

The Regensburg based biotech company Geneart GmbH announced the successful completion of the first clinical study of a HIV-vaccination, under the guidance of the European Research Consortium, EuroVacc, at the World Aids Conference in Thailand. This is the first confirmation of a promising development of the first vaccination against the immune deficiency known as AIDS.

read on

You might also be interested in: